Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis — Valuation, Growth & Financial Health

Five-Pillar Analysis for ARQT

TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes Arcutis Biotherapeutics, Inc. a strong or weak investment candidate.

▲ Valuation

Is ARQT priced fairly?

P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and ARQT's own history. Our valuation engine flags whether Arcutis Biotherapeutics, Inc. is trading rich, fair, or cheap.

▲ Profitability

How efficient is Arcutis Biotherapeutics, Inc.?

Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.

▲ Financial Health

Can ARQT survive a downturn?

Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen Arcutis Biotherapeutics, Inc.'s balance sheet for stress and flag liquidity or leverage risk.

▲ Returns

What's ARQT earning on capital?

Return on Equity, Return on Invested Capital, and Return on Assets. We compare Arcutis Biotherapeutics, Inc.'s capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.

▲ Growth

Is Arcutis Biotherapeutics, Inc. expanding?

Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.

→ Get the Full Picture

See the complete ARQT breakdown

Sign up free to unlock Arcutis Biotherapeutics, Inc.'s full five-pillar analysis with live financial data, peer comparisons, and historical context.

Sign up free →

Frequently Asked Questions about ARQT

Quick answers to the most common questions about Arcutis Biotherapeutics, Inc..

What does Arcutis Biotherapeutics, Inc. (ARQT) do?

Arcutis Biotherapeutics, Inc. is a publicly traded company under the ticker symbol ARQT. Sign up to TopTier Strategy to view a full business overview — including segments, competitive position, and how revenue is generated.

How do I analyze ARQT stock?

The five-pillar framework — Valuation, Profitability, Financial Health, Returns, and Growth — is the cleanest way to evaluate any stock, including ARQT. Each pillar uses standardized metrics that let you compare Arcutis Biotherapeutics, Inc. to its peers and to its own history.

Is ARQT a good stock to buy?

Whether Arcutis Biotherapeutics, Inc. fits your portfolio depends on your time horizon, risk tolerance, and investing style. TopTier Strategy gives you the structured data — valuation, profitability, balance sheet health, returns on capital, and growth — to make that decision with conviction.

Where can I see ARQT's financial data?

Sign up free at TopTier Strategy to access Arcutis Biotherapeutics, Inc.'s complete financial profile, including historical metrics, peer comparisons, and our five-pillar score breakdown.

Popular Stocks

Other widely-followed stocks investors research on TopTier Strategy.

Arcutis Biotherapeutics, Inc. (ARQT)